Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 18 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 11046670

    Piperazinyl norbenzomorphan compounds and methods for using the same

    The Board of Regents of the University of Texas System · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  2. US 11040959

    Diprovocims: a new and potent class of TLR agonists

    The Board of Regents of the University of Texas System · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  3. US 11033635

    Antibody-STING agonist conjugates and their use in immunotherapy

    The Board of Regents of the University of Texas System · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  4. US 11033611

    Compositions and methods for administration of an enzyme to a subject's airway

    The Board of Regents of the University of Texas System · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  5. US 11033612

    Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria

    The Board of Regents of the University of Texas System · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  6. US 11026889

    Polymeric drug delivery systems for treatment of disease

    The Board of Regents of the University of Texas System · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted
  7. US 11026960

    Esters of 2-deoxy-monosaccharides with anti proliferative activity

    The Board of Regents of the University of Texas System · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted
  8. US 11028083

    Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases

    The Board of Regents of the University of Texas System · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted
  9. US 11020383

    Methods for the treatment of cancer metastasis

    The Board of Regents of the University of Texas System · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  10. US 11021469

    Indoline sulfonamide inhibitors of DapE and NDM-1 and use of the same

    The Board of Regents of the University of Texas System · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  11. US 11021706

    Antisense antibacterial compounds and methods

    The Board of Regents of the University of Texas System · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  12. US 11013704

    Compounds supports hematopoietic stem cells and red blood cells

    The Board of Regents of the University of Texas System · Granted May 25, 2021 · Expires May 20, 2041

    granted
  13. US 11013818

    Library of pH responsive polymers and nanoprobes thereof

    The Board of Regents of the University of Texas System · Granted May 25, 2021 · Expires May 20, 2041

    granted
  14. US 11013740

    Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy

    The Board of Regents of the University of Texas System · Granted May 25, 2021 · Expires May 20, 2041

    granted
  15. US 11008372

    Targeting proteins for degradation

    The Board of Regents of the University of Texas System · Granted May 18, 2021 · Expires May 13, 2041

    granted
  16. US 11001594

    Heterocyclic modulators of HIF activity for treatment of disease

    The Board of Regents of the University of Texas System · Granted May 11, 2021 · Expires May 6, 2041

    granted
  17. US 11000602

    Delivery of small interfering RNA and micro RNA through nanogels containing hydrophobic pseudo-peptides

    The Board of Regents of the University of Texas System · Granted May 11, 2021 · Expires May 6, 2041

    granted
  18. US 10993983

    Cyclic peptide epitopes and small-molecule mimics for inducing autophagy

    The Board of Regents of the University of Texas System · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  19. US 10980841

    Methods and compositions for in vivo induction of pancreatic beta cell formation

    The Board of Regents of the University of Texas System · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  20. US 10982068

    Dendritic macroporous hydrogels prepared by crystal templating

    The Board of Regents of the University of Texas System · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  21. US 10981896

    Indolinone derivatives as inhibitors of maternal embryonic leucine zipper kinase

    The Board of Regents of the University of Texas System · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  22. US 10980847

    Compositions and methods for detecting and treating brain injury associated fatigue and altered cognition (BIAFAC)

    The Board of Regents of the University of Texas System · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  23. US 10975059

    Small molecule BRD4 modulators for HIV epigenetic regulation

    The Board of Regents of the University of Texas System · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted
  24. US 10975142

    Endotrophin neutralization and use thereof

    The Board of Regents of the University of Texas System · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted